How effective is natalizumab as second-line treatment for multiple sclerosis in daily clinical praxis?

Research output: Contribution to journalJournal articleResearchpeer-review

Udgivelsesdato: 2009/3
Original languageEnglish
JournalEuropean Journal of Neurology
Volume16
Issue number3
Pages (from-to)287-288
Number of pages1
ISSN1351-5101
Publication statusPublished - 2009

ID: 19662984